0 Commenti
0 condivisioni
653 Views
0 Anteprima
Cerca
Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie
-
Effettua l'accesso per mettere mi piace, condividere e commentare!
-
Bacillus Calmette-Guerin (BCG) Vaccine Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Executive Summary Bacillus Calmette-Guerin (BCG) Vaccine Market Size and Share Across Top Segments The global Bacillus Calmette-Guerin (BCG) vaccine market size was valued at USD 61.84 billion in 2024 and is expected to reach USD 92.06 billion by 2032, at a CAGR of 5.10% during the forecast periodThe market growth is primarily driven by the ongoing global efforts to control...0 Commenti 0 condivisioni 168 Views 0 Anteprima
-
Bacillus Calmette-Guerin (BCG) Vaccine Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Executive Summary Bacillus Calmette-Guerin (BCG) Vaccine Market Market Size and Share Forecast The global Bacillus Calmette-Guerin (BCG) vaccine market size was valued at USD 61.84 billion in 2024 and is expected to reach USD 92.06 billion by 2032, at a CAGR of 5.10% during the forecast periodThe market growth is primarily driven by the ongoing global efforts to control tuberculosis...0 Commenti 0 condivisioni 362 Views 0 Anteprima
-
Global Vaccine Adjuvants Market Industry – Key Players, Size, Trends, Opportunities, Growth- Analysis to 2025-2034The market research for the global Vaccine Adjuvants market is an accumulation of first-hand facts and quantitative and qualitative evaluation and analysis for the forecast period (2024-2032). The report offers a comprehensive assessment of macro-economic indicators, parent market trends, and several factors influencing the market dynamics. In addition, it also assesses the...0 Commenti 0 condivisioni 1K Views 0 Anteprima
-
Ad5-nCoV Vaccine Market Growth & CAGR 12.5% ForecastAccording to a newly published market research report by 24LifeSciences, the global Ad5-nCoV vaccine market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period 2025-2032. Ad5-nCoV, developed by CanSino Biologics, is a recombinant adenovirus type-5 vectored COVID-19 vaccine...0 Commenti 0 condivisioni 28 Views 0 Anteprima
-
Ad5-nCoV Vaccine Market Growth & CAGR 12.5% ForecastAccording to a newly published market research report by 24LifeSciences, the global Ad5-nCoV vaccine market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period 2025-2032. Ad5-nCoV, developed by CanSino Biologics, is a recombinant adenovirus type-5 vectored COVID-19 vaccine...0 Commenti 0 condivisioni 28 Views 0 Anteprima
-
Diphtheria, Tetanus and Pertussis Vaccine Market Companies: Growth, Share, Value, Size, and Insights"Executive Summary Diphtheria, Tetanus and Pertussis Vaccine Market : The global diphtheria, tetanus and pertussis vaccine market size was valued at USD 6.01 billion in 2024 and is projected to reach USD 9.75 billion by 2032, with a CAGR of 6.23% during the forecast period of 2025 to 2032. The Diphtheria, Tetanus and Pertussis Vaccine Market research report delivers...0 Commenti 0 condivisioni 3K Views 0 Anteprima
-
Human Papillomavirus Vaccine (HPV) Market Valuation to Touch US$ 7.71 Billion by 2034The Human Papillomavirus (HPV) Vaccine is formulated using virus-like particles that mimic the outer protein structure of the virus without containing its genetic material. This design ensures strong immunogenicity while maintaining a high safety profile. By targeting specific high-risk and low-risk HPV strains, the vaccine effectively prevents infections that may otherwise progress to...0 Commenti 0 condivisioni 1K Views 0 Anteprima
-
Market Outlook Report: Hepatitis B Therapeutics Demand, Forecast & OpportunitiesHepatitis B therapeutics are medical treatments used to suppress the hepatitis B virus and protect liver cells. They are critical in preventing disease progression. Regular follow-up is important. Hepatitis B Therapeutics Market Overview The Hepatitis B Therapeutics Market is projected to reach US$ 7.26 billion by 2031, growing at a CAGR of 8.8% during the forecast period from 2025 to...0 Commenti 1 condivisioni 1K Views 0 Anteprima
-
Meningococcal Polysaccharide Vaccine Market to Reach USD 4.5 Billion by 2030 | CAGR 6.3%According to a newly published market research report by 24LifeSciences, global meningococcal polysaccharide vaccine market was valued at USD 2.8 billion in 2023 and is projected to reach USD 4.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 2024-2030. Meningococcal polysaccharide vaccines are immunogenic preparations...0 Commenti 0 condivisioni 461 Views 0 Anteprima
-
Oral Vaccine Market Opportunities: Growth, Share, Value, Size, and Scope"Latest Insights on Executive Summary Oral Vaccine Market Share and Size The global oral vaccine market size was valued at USD 4.29 billion in 2025 and is expected to reach USD 7.48 billion by 2033, at a CAGR of 7.20% during the forecast period The market insights gained through this keyword market research analysis report facilitate a more defined...0 Commenti 0 condivisioni 1K Views 0 Anteprima
-
Smart Glasses Market Revenue Analysis: Growth, Share, Value, Size, and Insights"Executive Summary Smart Glasses Market : Smart glasses market will grow at a rate of 12.00% for the forecast period of 2021 to 2028. Smart glasses market report analyses the growth, which is currently being growing due to rising demand for smart glass in automobile applications Smart Glasses Market analysis report is a professional and a detailed market study focusing on primary...0 Commenti 0 condivisioni 14K Views 0 Anteprima
Pagine in Evidenza
Sponsorizzato
Sponsorizzato
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek